摘要
目的探讨莫沙必利联合泮托拉唑治疗胃食管反流的临床疗效。方法收集我院治疗的84例胃食管反流患者,将患者完全随机分为治疗组和对照组,每组42例,治疗组患者采用莫沙必利联合泮托拉唑治疗,对照组患者采用泮托拉唑治疗,比较两组患者的治疗效果。结果治疗组患者总有效率为95.2%,明显高于对照组的73.8%,差异有统计学意义(P<0.05)。结论莫沙必利结合泮托拉唑治疗胃食管反流的临床疗效明显。
Objective To explore the clinical therapeutic effect of Mosapride combined with pantoprazole in the treatment of gastroesophageal reflux disease.Methods We selected 84 cases of gastroesophageal reflux disease in our hospital patients,the patients were randomly divided into treatment group and control group,42 cases in each group,the treatment group was treated with Mosapride combined with pantoprazole in the treatment,patients in control group were treated by pantoprazole treatment,compared two groups of patients with treatment effect.Results The patients in the treatment group the total effective rate was 95.2%,significantly higher than 73.8% in the control group, the difference was statistically significant(P〈0.05).Conclusion The clinical therapeutic effect of Mosapride combined with pantoprazole in the treatment of gastroesophageal reflux disease is remarkable.
出处
《中国药物经济学》
2015年第5期83-85,共3页
China Journal of Pharmaceutical Economics
关键词
胃食管反流
莫沙必利
泮托拉唑
Gastroesophageal reflux disease
Mosapride
Pantoprazole